Skip to content
Pharma Observatory a Scientist.com platform

Organization (Government)

Secretaria de Salud

ClinicalTrials.gov lists Secretaria de Salud as lead sponsor of 194 trials, counting the companies grouped under it.

MX Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Companies grouped under this page Companies grouped under this page 5 Related companies not grouped here Related companies not grouped here 2 Disease areas Disease areas 209 Journals published in Journals published in 739 US granted patents US granted patents 1 Organization relationships Organization relationships 54 Latest dated events Latest dated events 275 Biomarkers this organization publishes on Biomarkers this organization publishes on 658 Companies grouped under this page Companies grouped under this page 5 Related companies not grouped here Related companies not grouped here 2 Disease areas Disease areas 209 Journals published in Journals published in 739 US granted patents US granted patents 1 Organization relationships Organization relationships 54 Latest dated events Latest dated events 275 Biomarkers this organization publishes on Biomarkers this organization publishes on 658

Rows recorded per section (log scale)

16 sections measured, none recorded

Logo Gobierno de México, via Wikimedia Commons, CC0. Shown to identify the organization; it may be a registered trademark.

This page covers Secretaria de Salud and 5 companies grouped under it: 194 lead-sponsored trials (0 its own, 194 in the grouped companies) and 7 legal-entity registrations (2 its own, 5 in the grouped companies).

Related companies are recorded in the same corporate group by GLEIF, ROR or a curator but are not grouped here; they are listed below with their own counts and are not included in the figures above.

Get the Secretaria de Salud report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Companies grouped under this page (5)

Shown in this order: most lead trials first.

Companies grouped under this page
Company Lead trials Legal entities
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán 144 1
Hospital General de México 28 1
Instituto Nacional de Enfermedades Respiratorias 17 1
Instituto Jalisciense de Cancerología 3 1
Hospital General Dr. Manuel Gea Gonzalez 2 1

Disease areas (209)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Obesity 25
COVID-19 24
Diabetes Mellitus 24
Fibrosis 24
Diabetes Mellitus, Type 2 16

Showing 5 of 209 disease areas.

Start your 14-day trial Email me the first 50 disease areas as a PDF

Journals published in (739)

Shown in this order: most published in first.

Journals published in
Journal Publications
The New England journal of medicine 34
The American journal of clinical nutrition 25
The Journal of nutrition 24
Lancet (London, England) 21
AIDS (London, England) 18

Showing 5 of 739 journals.

Start your 14-day trial Email me the first 50 journals as a PDF

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
11 2 2024-12-24

Organization relationships (54)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
National Council of Science and Technology, Mexico Co sponsors trial with 5
Mexican Social Security Institute Co sponsors trial with 4
Instituto Nacional de Salud Publica, Mexico Co sponsors trial with 4
Universidad Nacional Autónoma de México Co sponsors trial with 4
Instituto Nacional de Cancerologia de Mexico Co sponsors trial with 4

Showing 5 of 54 relationships.

Start your 14-day trial Email me the first 50 relationships as a PDF

Latest dated events (275)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-08-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-07-10 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-05 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-05-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-04 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 275 events.

Start your 14-day trial Email me the first 50 events as a PDF

Biomarkers this organization publishes on (658)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
CRP 57
INS 33
TNF 33
IL6 31
IFNG 25

Showing 5 of 658 biomarkers.

Start your 14-day trial Email me the first 50 biomarkers as a PDF

Not on this page

Checked, with nothing recorded for this organization: trials by start year as sponsor or collaborator, active development programs, approved assets, sponsor delivery record, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarker capability evidence.